PRE Prenetics Global
Prenetics Global earnings company data as of 4:48 AM ET 10/23
- 0 of 1 EPS beats
History
2 periods, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 9 Nov | EPS | — | — | — |
| Rev | — | — | — | ||
| FY2026 Q2 | 18 Aug | EPS | -0.48 | -0.52 | Miss |
| Rev | — | $45.0M | — |
Insider trades
Open-market buys and sales by PRE's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $1M bought by 2 insiders
- None no sales outside a trading plan
- None no planned (10b5-1) sales
-
Brian J Rosin CFOBuy$498K 23,100 shares at $21.55 New stakeTraded Aug 24–25 Filed Aug 26
-
Danny Sheng Wu Yeung CEOBuy$502K 24,681 shares at $20.34 +28% to stakeTraded Aug 20–24 Filed Aug 24
Also filed in the last 12 months, not counted as buying or selling: 10 option exercises and 1 other transaction.
SEC filings
Recent issuer filings from EDGAR, 25 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 6-K | Filing Doc | ||
| 20-F/A | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 20-F/A | Filing Doc | ||
| 6-K | Filing Doc | ||
| 20-F/A | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 20-F | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.